167 related articles for article (PubMed ID: 12475736)
1. Essential thrombocythemia (ET): moving from palliation to cure.
Tsimberidou AM; Giles FJ
Hematology; 2002 Dec; 7(6):315-23. PubMed ID: 12475736
[TBL] [Abstract][Full Text] [Related]
2. [Treatment outcome of patients with essential thrombocythemia at our department in Hungary].
Iványi JL; Marton É; Plander M; Szendrei T
Orv Hetil; 2016 Feb; 157(9):336-41. PubMed ID: 26895801
[TBL] [Abstract][Full Text] [Related]
3. A critical review of anagrelide therapy in essential thrombocythemia and related disorders.
Dingli D; Tefferi A
Leuk Lymphoma; 2005 May; 46(5):641-50. PubMed ID: 16019501
[TBL] [Abstract][Full Text] [Related]
4. [Primary thrombocythemia: diagnosis and therapy].
Petrides PE
Med Klin (Munich); 2006 Aug; 101(8):624-34. PubMed ID: 16896569
[TBL] [Abstract][Full Text] [Related]
5. Indications for lowering platelet numbers in essential thrombocythemia.
Barbui T
Semin Hematol; 2003 Jan; 40(1 Suppl 1):22-5. PubMed ID: 12682878
[TBL] [Abstract][Full Text] [Related]
6. How to manage essential thrombocythemia.
Finazzi G
Leukemia; 2012 May; 26(5):875-82. PubMed ID: 22051530
[TBL] [Abstract][Full Text] [Related]
7. Essential thrombocythaemia treatment options: addressing patient-specific needs.
Birgegård G
Eur J Haematol Suppl; 2007 Oct; (68):27-31. PubMed ID: 17727563
[No Abstract] [Full Text] [Related]
8. Anagrelide compared with hydroxyurea in essential thrombocythemia: a meta-analysis.
Samuelson B; Chai-Adisaksopha C; Garcia D
J Thromb Thrombolysis; 2015 Nov; 40(4):474-9. PubMed ID: 25894476
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of essential thrombocythemia].
Alvarez-Larrán A; Cervantes F; Besses C
Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of anagrelide in treatment of essential thrombocythemia: multicenter, randomized controlled clinical trial].
Ge X; Yang L; Jin J; Qian W; Li J; Yang R; Cao X; Jiang B; Wang Z; Hou M; Zhang W; Xiao Z; Zhao Y; Gao D; Zhang X; Wang S; Sun A; Fu J; Su L; Li K
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):547-52. PubMed ID: 26304075
[TBL] [Abstract][Full Text] [Related]
11. Essential Thrombocythemia: The Dermatologic Point of View.
Cozzani E; Iurlo A; Merlo G; Cattaneo D; Burlando M; Pierri I; Gugliotta L; Parodi A
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):739-47. PubMed ID: 26432058
[TBL] [Abstract][Full Text] [Related]
12. [Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].
Penka M; Doubek M; Schwarz J; Pytlík R; Dulícek P; Kissová J; Hlusí A; Vozobulová V; Cerná O; Brychtová Y; Szotkowski T; Volková Z; Seghetová J; Schutzová M; Hadacová I; Hochová I; Voglová J; Siroký O; Belada D; Lhot'anová T; Bubeník B; Vránová M; Micaníková M; Dusek L
Vnitr Lek; 2006 May; 52(5):498-503. PubMed ID: 16771099
[TBL] [Abstract][Full Text] [Related]
13. Practical approach to treating essential thrombocythaemia: case studies.
Reilly JT
Eur J Haematol Suppl; 2007 Oct; (68):40-2. PubMed ID: 17727566
[No Abstract] [Full Text] [Related]
14. Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis.
Mesquita Mdo C; Sol EB; Malarme M; Noubouossie D; Demulder AC
Clin Ther; 2009 Nov; 31(11):2559-64. PubMed ID: 20110000
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia.
Alvarado Y; Cortes J; Verstovsek S; Thomas D; Faderl S; Estrov Z; Kantarjian H; Giles FJ
Cancer Chemother Pharmacol; 2003 Jan; 51(1):81-6. PubMed ID: 12497210
[TBL] [Abstract][Full Text] [Related]
16. Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications.
Tefferi A; Silverstein MN; Petitt RM; Mesa RA; Solberg LA
Semin Thromb Hemost; 1997; 23(4):379-83. PubMed ID: 9263355
[TBL] [Abstract][Full Text] [Related]
17. Long-term management of thrombocytosis in essential thrombocythaemia.
Birgegård G
Ann Hematol; 2009 Jan; 88(1):1-10. PubMed ID: 18629498
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of essential thrombocythemia].
Costello R; O'Callaghan T; Sébahoun G
Rev Med Interne; 2005 Dec; 26(12):947-55. PubMed ID: 16122842
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of essential thrombocythemia].
Kuramoto A
Rinsho Ketsueki; 1995 May; 36(5):480-6. PubMed ID: 7783354
[TBL] [Abstract][Full Text] [Related]
20. Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".
Mazzucconi MG; Baldacci E; Latagliata R; Breccia M; Paoloni F; Di Veroli A; Cedrone M; Anaclerico B; Villivà N; Porrini R; Montefusco E; Andriani A; Montanaro M; Scaramucci L; Spadea A; Rago A; Cimino G; Spirito F; Santoro C
Eur J Haematol; 2020 Sep; 105(3):335-343. PubMed ID: 32441419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
